JFGIW
PCRX icon

Johnson Financial Group Inc (Wisconsin)’s Pacira BioSciences PCRX Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3
Closed – – 778
2021
Q4 		$0 Sell
3
-3
-50% -$165 ﹤0.01% 818
2021
Q3 		$0 Hold
6
– – ﹤0.01% 783
2021
Q2 		$0 Buy
+6
New +$380 ﹤0.01% 791
2016
Q3 		– Sell
-274
Closed -$9K – 734
2016
Q2 		$9K Buy
274
+225
+459% +$11.1K ﹤0.01% 672
2016
Q1 		$3K Hold
49
– – ﹤0.01% 682
2015
Q4 		$4K Hold
49
– – ﹤0.01% 700
2015
Q3 		$2K Hold
49
– – ﹤0.01% 771
2015
Q2 		$3K Buy
+49
New +$3.86K ﹤0.01% 796
2013
Q3 		– Sell
-122
Closed -$4K – 703
2013
Q2 		$4K Buy
+122
New +$3.53K ﹤0.01% 640

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return